MAPKAP1 and Huntington disease: We found that the hemodialysis process primarily inhibited the PI3K-Akt-mTOR pathway of TCR downstream signaling, since ITGA, IL7R, JAK1, PI3K, MAPKAP1, RPS6, EIF4B, and PCRKA showed significantly decreased levels in HD patients.